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A b s t r a c t  
Background: Proteins possess greater biochemical and structural complexity compared to 
conventional drug based pharmaceuticals. In the present study, we investigated the effect of 
compression force on the tablet properties, primarily the enzyme activity and the percolation 
threshold to have more information of behaviour of đ- Amylase powder under compaction along with 
detection of mixture range in which enzyme is protected by the excipients.  
Results: The results showed that carrageenan, tragacanth and agar provided the maximum 
protection to enzyme activity compared to microcrystalline cellulose and dicalcium phosphate 
dihydrate on compaction. However stability studies indicated the highest loss of enzyme activity with 
carrageenan, tragacanth and agar. The compressibility studies of different binary mixtures of đ- 
Amylase with microcrystalline cellulose indicated that đ- Amylase behaves like a brittle substance. 
The application of percolation theory on the relationship between the critical density as a function of 
enzyme activity and mixture composition revealed the presence of percolation threshold for binary 
mixture. đ- Amylase ă microcrystalline cellulose mixture composition showed significant percolation 
threshold at 37.23 % (w / w) đ- Amylase loading.  
Conclusion: Microcrystalline cellulose provided higher protection during stability study. However, 
higher concentrations of microcrystalline cellulose, probably as dominant particles do not protect the 
enzyme with their plastic deformation. Below the percolation threshold i.e. 37.23 % (w / w) đ- 
Amylase amount in mixture with plastic excipient, activity loss increases strongly because of higher 
shearing forces during compaction due to system dominance of plastic particles. This mixture range 
should therefore be avoided to get robust formulation.   
Keywords: đ- amylase, microcrystalline cellulose, compressibility, percolation threshold. 
Introduction 
Among the new drug substances, the use of proteins and peptides 
as pharmaceuticals is steadily increasing, especially with evolution 
of recombinant DNA technique and advances in proteomics. 
Proteins possess greater biochemical and structural complexity 
compared to conventional drug based pharmaceuticals [1]. Thus, 
the formulation and delivery of proteins into stable well 
characterised and efficacious drug products represent significant 
challenges to pharmaceutical scientist [2]. Tablets are suitable 
dosage form for application of these materials as it provides ease 
of administration, metering accuracy, robustness, good stability 
and efficient production. However, simple compression of a bulk 
material, either powder or granulate, to a robust tablet is dependent 
on a great number of influences, mainly compression force, particle 
deformation and formation of adhesive forces. Therefore, the 
physical and chemical properties of protein can be influenced by 
formulation and technological factors for e.g. excipients, 
temperature, storage conditions, compression or shear forces [3].  
Pharmaceutical tablets generally comprise a number of 
components, which all contribute to the final properties of tablets. 
However, this is a challenging task to predict the properties of the 
tablets based upon the knowledge of material properties of 
constituent substances due to the complexity and density of 
pharmaceutical blends. Therefore, an alternative approach would 
be to identify the dominant substance in terms of properties of 
interest, and to predict the tablet properties from properties of two 
or more of these dominant constituents by the application of 
percolation theory [4]. Many tablet properties are related to the 
relative density of a tablet. The percolation theory relates changes 
in tablet properties to the existence of critical points in 
pharmaceutical formulations which can be related to the 
percolation threshold of a compact of the formulation [5, 6]. The 
knowledge of these critical points and corresponding percolation 
thresholds is of great importance to optimise the design of 
pharmaceutical dosage form. Furthermore, in order to prepare 
robust formulations, the neighbourhood of percolation thresholds 
should be avoided. Otherwise a little change in the concentration of 
one component can cause a high variability in the properties of 
formulation. 
α- Amylase is a major enzyme used for replacement of pancreatic 
enzyme during pancreatitis, cystic fibrosis or surgical removal of 
pancreas [7, 8]. Amylases are produced by a wide spectrum of 
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organisms [9]. Amylases from the source other than pancreas can 
also be used for replacement [10, 11]. Fungal enzymes have the 
advantages of high catalytic rate at moderate temperature 
compared to bacterial enzymes. Therefore, đ- Amylase from 
Aspergillus oryzae was used as model enzyme in this work.   
The approach of the present work is the compaction of enzyme (đ- 
amylase) to get more information about the tablet property i.e. the 
enzyme activity under pressure [12, 13]. Therefore, the primary 
objective of the research work was detection of a percolation 
threshold to get more information of powder behaviour under 
compaction and to find out a mixture range in which the enzyme is 
protected by excipient. 
Materials and methods 
Materials  
Microcrystalline cellulose (MCC) (Avicel® PH 102), dicalcium 
phosphate dihydrate (DCP), magnesium stearate, soluble starch, 
carrageenan, agar, tragacanth and 3,5 dinitrosalicylic acid (DNS) 
were purchased from Himedia Laboratories Pvt. Ltd., Mumbai, 
India. Potassium dihydrogen phosphate, sodium hydroxide 
(Qualigens Fine Chemicals, Mumbai, India) and Fungal đ- Amylase 
(source Aspergillus oryzae), sodium potassium tartarate, sodium 
carbonate, copper sulphate and FolinÊs reagent were purchased 
from S. D. Fine- Chem Ltd., Mumbai, India. All chemicals were 
used as received. Double ă distilled water was used throughout the 
study. 
Methods 
Enzyme assay 
Amylase activity was determined according to the procedure of 
Bernfeld et al. [14] after some modifications. Appropriately diluted 
enzyme was added to 1 ml of buffered soluble starch (1 % w/v) 
substrate solution (pH 6.0). After incubation at 37 ĈC for 5 min in a 
shaking water bath, the reaction was stopped by the addition of 2 
ml of 3, 5- dinitrosalicylic acid (DNS) reagent (1 % w/v DNS in 30 
% w/v sodium potassium tartarate and 1.6 % w/v sodium 
hydroxide). The tubes were kept in boiling water bath for 10 min to 
develop colour and cooled. The absorbance was read at 540 nm in 
a spectrophotometer, after making up the volume to 10 ml. 
Amylase activity was expressed as mg of maltose liberated in 5 
min by 1 mg enzyme under assay conditions. The amount of 
maltose formed in test samples was calculated using a calibration 
curve of maltose prepared by plotting absorbance versus  
concentration of maltose (mg/ml) in distilled water at 540 nm using 
UV / VIS spectrophotometer (Lab-India® UV 3000+, India).   
Influences on enzyme (đ- amylase) activity 
Enzymes are known to be sensitive to different stresses. Thus, it 
was important to test if temperature or excipients could influence 
the activity of enzyme powder. 
Temperature 
The influence of different temperatures on the dry enzyme powders 
of đ- Amylase was investigated. The dry powder was exposed to 
30, 40, 50, 60, 70 and 80 ĈC for 5 min i.e. the duration of 
compaction process. After this exposition, the enzyme activity was 
determined. 
Excipients 
The influence of various excipients, which have contact with the 
enzyme powder during powder compression, was investigated. 
Thus, dispersions of 50 % enzyme with 50 % MCC, DCP, 
carrageenan, agar or tragacanth was prepared in phosphate buffer 
(pH 6.0) and the enzyme activity was detected and compared with 
reference.   
Preparation of tablets of enzyme with different 
excipients 
Binary mixture of enzyme (đ- amylase) with MCC, DCP, 
carrageenan, agar and tragacanth were prepared in 1:1 ratio, 
respectively. The powders were mixed manually for 5 min. 
Samples comprising 200 mg of binary mixture powder were 
manually filled into a die of 8 mm in diameter (Cadmach Machinery 
Private Ltd., Ahmedabad) at 80 MPa compression pressure and 
the powders were compressed. Different batches of tablets 
prepared with various excipients are coded as given in Table 1. For 
each system 20 tablets were compressed. From the compression 
process only out of die data were generated. 
 
 
Table 1. Different batches of tablets prepared with MCC, DCP, carrageenan, agar and tragacanth.  
Excipients Excipient : Enzyme ratio Formulation code for - Amylase tablets 
Nil - AP
MCC 1:1 AM
DCP 1:1 AD
Carrageenan 1:1 AC
Agar 1:1 AA
Tragacanth 1:1 AT
*AP represents tablets of đ- Amylase powder. 
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Stability study of tablets 
Different batches of tablets were packed in amber coloured glass 
bottles and subjected to stability testing according to the 
International Conference on Harmonization guidelines for zone III 
and IV. The packed containers were kept for accelerated (40 μ 2 ĈC 
/ 75 μ 5 % relative humidity) and long term (30 μ 2 ĈC / 65 μ 5 % 
relative humidity) stability for 6 months and 12 months, 
respectively. Samples kept under accelerated storage conditions 
were withdrawn at 0, 1.5, 3 and 6 months and đ- Amylase activity 
were estimated. Similarly, samples stored at 30 μ 2 ĈC / 65 μ 5 % 
were withdrawn at 0, 3, 6, 9 and 12 months, and analysed for đ- 
Amylase activity. Visual inspection of samples for discoloration of 
tablet content was also done after completion of stability study. 
Compaction behaviour of enzymes with MCC 
Preparation of compact with MCC 
Compacts of đ- amylase, MCC, DCP and binary mixtures of MCC 
and đ- Amylase were prepared respectively. Binary mixtures of 
MCC and enzyme were prepared with different fractions of 
constituent components. These binary mixtures consist of following 
amounts of đ- Amylase i.e. 1, 20, 40, 60, 80 % (w/w). The powders 
were mixed manually for 5 min. Samples comprising 200 mg of 
binary mixture powder were manually filled into a die of 8 mm in 
diameter (Cadmach Machinery Private Ltd., Ahmedabad) and the 
powders were compressed and decompressed without holding 
between the compression and decompression stages. Tablets with 
different densities were produced by varying the total compression 
pressure ranging from 40 MPa to 280 MPa. For each system and 
compaction pressure, 20 tablets were compressed. From the 
compression process only out of die data were generated. 
Determination of relative density and porosity of 
compact 
The tablet weight was measured using an electronic balance 
(Shimadzu AUY 220, Japan). The diameter and the thickness were 
measured with vernier calliper after a storage time of 24 h at 45 % 
relative humidity in a desiccator. From these measurements, the 
apparent volume and apparent density of the tablets were 
determined. The apparent density, ρa was then determined by  
 
   ρa = Tablet weight / Apparentvolume(Vtot)                                  (i) 
 
The true density (ρt) of the powder was measured, using a helium 
gas displacement pycnometer (Type AccuPyc 1330, 
Micromeritics®, Bedfordshire, UK). 
The relative density (ρr) was calculated by dividing the tablet 
apparent density by the true density of the binary mixture of 
powders used. 
             ρr = ρa / ρt = Vt / Vtot                                                         (ii) 
 
Vt characterises the true volume of the solid particles and therefore 
equation (ii) shows that the relative density is essentially a solid 
fraction.  
The relative porosity (ē) of the compact is then calculated as 
           = (Vtot ă Vt) / Vtot = 1 ă Vt / Vtot  = 1 - ρr                             (iii) 
Heckel analysis 
The compaction characteristics of the powder were studied by 
plotting ăln(porosity) vs. compaction pressure according to Heckel 
equation [15]   
 
              ln (1/1-ρr) = KP + A                                       (iv) 
 
Where, ρr is the relative density of the compact, P is the applied 
pressure; K (the slope of the linear portion) is the reciprocal of the 
yield pressure, Py, of the material. The yield pressure is inversely 
related to the ability of the material to deform plastically under 
pressure and A is a function of the original compact volume.  
Determination of percolation threshold  
According to the percolation theory, critical normalised density (a 
function of tablet property) of various binary systems was 
determined by plotting enzyme activity as a function of normalised 
density (Apparent density / Poured density) of compact under 
different compression pressure [5]. The critical normalised density 
of various systems was determined by dividing the data in the 
curve into two straight lines using equation 
 
y=A(m1x+b1)+B(m2x+b2)                                  (v) 
 
where x is the relative density of compact, y is compaction 
pressure, m is the slope, b is intercept, A and B are constants. The 
data points around the critical value shown as a bend in the curve 
were attributed alternatively to the first section or to the second 
section. The final attribution was made considering the correlation 
coefficient R2 for the overall fit. 
The critical normalised density (a function of tablet property) 
changes in the vicinity of percolation threshold of material in binary 
mixture [16]. Percolation threshold of different binary mixtures of đ- 
Amylase and microcrystalline cellulose was determined by plotting 
critical normalised density of various systems against the 
percentage concentration of đ- Amylase in binary mixture using 
equation (v).      
Results and discussion 
Influences on enzyme activity 
The influence of temperature and different excipients on the 
enzyme (đ- amylase) activity was tested. These investigations led 
to necessary information concerning the stability of the enzyme 
powder. This knowledge is important for characterisation of the 
enzyme powder and thus for further treatment of the enzyme 
powder preparation in the different studies. 
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Temperature 
The exposure of dry enzyme powder to different temperatures for 
the time of a compaction process had not showed any significant 
change in the activity from 40 to 80 ĈC (Figure 1). The problems are 
not expected to arise from temperature development in die for 
tablet compaction of dry enzyme powder. Temperature arise over 
80 ĈC during compression is not probable [17, 18]. Hence, possible 
activity loss during compression may not derive from a warming in 
die.  
 
Figure 1. Effect of temperature on the stability of bulk enzyme 
(alpha- amylase) powder. 
Excipients 
The behaviour of the activity of đ- Amylase in the presence of 
various excipients was investigated and compared to the activity of 
α- Amylase powder as reference. The difference between the 
reference and the solutions of đ- Amylase powder and excipient, i.e. 
MCC, DCP, carrageenan, agar or tragacanth was not significant as 
the activity of enzyme remained almost same. Hence, influence of 
these excipients on the activity of đ- Amylase is not evident. 
Enzyme activity of tablets 
Compacts of α- Amylase along with various excipients i.e. MCC, 
DCP, carrageenan, agar and tragacanth showed decrease in 
enzyme activity respectively, when compared with the reference 
standards (Table 2). The greater loss in activity was observed with 
DCP and MCC compared to carrageenan, agar and tragacanth.    
 
Table 2. Effect of compaction of enzyme (đ- amylase) with different 
excipients on activity of enzyme.  
Formulation % Activity remaining
AP 86.47 μ 4.13
AM 85.43 μ 3.18
AD 83.27 μ 2.56
AC 92.01 μ 3.45
AA 90.53 μ 2.67
AT 91.11 μ 4.32
             *Values are mean μ SE (n = 3). 
Stability studies of tablets 
Tables 3 and 4 present the results of accelerated and long-term 
stability studies of compacts and bulk đ- Amylase formulations. The 
tablet formulations AM and AD showed around 89 % α- Amylase 
content on storage under accelerated conditions (i.e. 40 ĈC / 75 % 
RH) for 6 months while AC, AA, AT and α- Amylase tablets 
showed 84 and 78 % drug content respectively (Table 3). AM and 
AD, however, showed around 88 % drug content when stored at 30 
ĈC / 65 % RH for 12 months against 78.58 % drug content for AP 
formulation. AC, AA and AT formulations showed around 85 % 
drug content when stored under similar conditions for 12 months. 
The results suggest improved stability of the enzyme on 
compaction with excipients. On the basis of first order degradation 
rate constants, the calculated t90 of AM, AD, AC, AA and AT at 30 
ĈC/ 65 % RH would be 341, 308, 268, 236, and 250 days 
respectively (Table 4). The Kcalc / t90 values suggest that 
formulations will not provide 1 year shelf life (t90) of the product and 
would need larger amount of overages resulting in higher initial 
drug concentration. The colour of α- Amylase compacts along with 
carrageenan, agar and tragacanth changed from pale buff to dark 
brown whereas α- Amylase compact formulations with MCC and 
DCP changed from pale buff to light brown. Thus, the stability of α- 
Amylase compacts along with excipients like carrageenan, agar 
and tragacanth was significantly lesser than compacts with MCC 
and DCP. The loss of enzyme activity with carrageenan, agar and 
tragacanth was more because of their greater moisture adsorption 
capacity. Thus, stability of compacts can be enhanced if protection 
is given against moisture to the compacts. However, greater 
amount of decrease in activity was observed during compaction of 
enzyme (α- amylase) with MCC compared to carrageenan, agar 
and tragacanth. Therefore, it becomes imperative to study the 
compression behaviour of enzyme i.e. α- Amylase along with 
MCC. 
Compression behaviour  
According to Heckel analysis, on plotting ăln (porosity) against 
compaction pressure, it was observed that α- Amylase and DCP 
behave very similarly contrary to MCC (Figure 2). Slopes of curves 
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(K values) of đ- Amylase and DCP were 0.0068 MPa-1 (R2 = 0.995) 
and 0.0079 MPa-1 (R2 = 0.994), respectively, whereas the K value 
of MCC was 0.0226 MPa-1 (R2 = 0.980). K value for MCC confirms 
the fact that plastic substances have higher K values than brittle 
substances [15, 19].  As DCP is known to have brittle properties, α- 
Amylase powder can be classified as brittle substance. However 
the comparison of MCC with binary mixture of đ- Amylase ă MCC in 
1:1 ratio showed that there is no linear relationship between the 
Heckel plot of excipient alone and along with enzyme. A slight 
dominance of α- Amylase in the Heckel plot was seen (Figure 2). 
The K values confirmed the statement i.e. K = 0.0099 MPa-1, 
0.0226 MPa-1 and 0.0068 MPa-1 for binary mixture of α- Amylase - 
MCC (1:1), MCC and α- amylase, respectively. 
 
 
 
Table 3. Stability of enzyme (α- amylase) powder tablet alone and in combination with different excipients under Accelerated Storage Conditions 
(40 μ 2 ĈC / 75 μ 5 % RH) 
Formulation % Activity remaining K
(Days-1) 
0 M 1.5 M 3 M 6 M 
AP 100.00 μ 3.20 95.87 μ 2.75 86.56 μ 3.18 77.84 μ 2.87 1.39 X 10-3
AM 100.00 μ 2.08 97.88 μ 2.14 94.86 μ 2.66 89.20 μ 2.32 6.35 X 10-4
AD 100.00 μ 2.48 96.47 μ 2.61 93.50 μ 4.64 88.71 μ 3.16 6.66 X 10-4
AC 100.00 μ 2.19 97.08 μ 3.52 91.70 μ 2.88 84.26 μ 2.32 9.52 X 10-4
AA 100.00 μ 2.08 96.74 μ 2.94 90.85 μ 2.66 85.35 μ 2.68 8.80 X 10-4
AT 100.00 μ 2.28 95.47 μ 3.93 91.59 μ 2.65 84.11 μ 2.67 9.61 X 10-4
*Values are mean μ SE (n = 3), M: months, Kcal : calculated first ă order degradation rate constant 
 
Table 4. Stability of enzyme (α- amylase) tablet alone and along with different excipients under Room Temperature Storage (30 μ 2 ĈC / 65 μ 5 
% RH). 
Formulation % Activity remaining K 
(Days-1) 
t90 (Days)
 0 M 3 M 6 M 9 M 12 M
AP 100.00 μ 
1.57 
94.41 μ 
1.38 
90.42 μ 
1.18 
85.08 μ 
1.35 
78.58 μ 
1.26 
6.61 X 10-4 157.45
AM 100.01 μ 
2.08 
97.05 μ 
2.62 
94.41 μ 
2.05 
92.12 μ 
2.23 
89.48 μ 
1.62 
3.05 X 10-4 341.44
AD 100.00 μ 
1.48 
96.03 μ 
2.43 
93.36 μ 
2.21 
90.99 μ 
2.43 
88.43 μ 
2.11 
3.37 X 10-4 308.67
AC 100.00 μ 
2.19 
96.01 μ 
3.09 
92.53 μ 
2.55 
89.48 μ 
2.92 
86.83 μ 
2.46 
3.87 X 10-4 268.76
AA 100.00 μ 
2.08 
96.01 μ 
2.52 
92.92 μ 
2.76 
89.83 μ 
2.58 
85.19 μ 
2.71 
4.39 X 10-4 236.78
AT 100.00 μ 
2.28 
95.74 μ 
2.51 
92.66 μ 
2.75 
89.58 μ 
2.57 
85.95 μ 
2.71 
4.15 X 10-4 250.67
*Values are mean μ SE (n = 3), M: months, Kcal : calculated first ă order degradation rate   constant, t90: time to reach 90% of initial drug 
concentration. 
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Figure 2. Heckel plots of comparison of đ- amylase, DCP, MCC and 
alpha- amylase ă MCC binary mixture (1:1). 
 
The behaviour of the enzyme under compression was further 
characterized by determining the activity loss at different 
compression pressure (Figure 3). The enzyme activity decreased 
steadily up to a compaction pressure of 160 MPa whereas at 
higher compaction pressures, the curve flattened and the degree of 
the activity loss decreased. Comparison with the porosity of the 
tablets showed that the curve also flattened slightly after the 
pressure of 160 MPa. The correlation coefficient r of activity of đ- 
Amylase with the porosity of their respective tablets showed a 
value of 0.984, suggesting a positive correlation. This correlation 
can be explained with the reduction of interparticle space, which is 
big in the stage of particle movement and rearrangement and 
diminishes in the stage of particle deformation and therefore by a 
destruction of the native state of the enzyme under compression. 
This destruction is probably linear in the stage of particle 
movement and rearrangement. In the stage of deformation, i.e. the 
region of the flattening slope, shearing forces will probably 
decrease as a consequence of the reduced particle movement. 
 
 
 
Figure 3. Relationship between alpha- amylase activity loss and 
porosity of tablet with increase of compression pressure. 
 
Determination of critical density 
Enzyme activity was analyzed as a function of the apparent density 
of compact. The apparent density of compact is a result of 
compaction pressure applied. Before compression, 100 % of 
enzyme activity was observed for the material. The apparent 
density of compact was normalized with the poured density of 
material before compression. Thus, for the normalised relative 
density ρn = 1, 100 % enzyme activity and for the higher values for 
ρn, the respective value of enzyme activity were measured. The 
relationship between activity and density of the compacts analysed 
with different composition of binary mixture of excipient and 
enzyme (α- amylase) is shown in Figure 4. The curves so obtained 
with different binary mixtures were approximated with two linear 
sections using equation (v) and each section was linearised by two 
regression lines. The intersection of two regression lines was 
determined as critical normalised density. Thus for each mixture, a 
critical normalised density was obtained, where the enzyme activity 
loss becomes more important. At higher compaction pressures, the 
degree of activity loss is more [20]. Figure 4 also shows that the 
activity loss at very high pressures depends only on the final 
apparent density of the compact (out-of-die).  
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Figure 4. Relationship between alpha- amylase activity remaining (%) in tablet with density on compaction of different binary mixtures of alpha- 
amylase with MCC. 
The detected critical normalized densities of various binary α- 
Amylase - MCC powder mixtures were plotted as a function of the 
amount of α- Amylase (Figure 5). The plot was divided into two 
sections with a squared correlation coefficient R2 of 0.999 for 
section 1 and 0.964 (Figure 5), respectively. The point of 
intersection i.e. 37.23 % (w / w) (Figure 5) indicates the critical 
concentration of α- Amylase for binary mixtures with MCC, 
respectively. This critical α- Amylase concentration can be 
interpreted as the percolation threshold of these binary mixture 
system. It defines the point where the system dominance of MCC 
is replaced by the dominance of α- amylase. Above the percolation 
threshold, the brittle substance (α- Amylase powder) builds a 
lattice. The rigidity of the lattice and the filling of pore spaces with 
MCC particles prevent the fracturing of the brittle particles and 
therefore reduce the shearing forces in the compact. This seems to 
be favourable and reduces the loss of enzyme activity (Figure 6).  
 
Figure 5. Relationship between critical densities of each binary 
mixture of alpha- amylase with MCC and the amount of alpha- 
amylase (%). 
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Below the percolation threshold, the enzyme is completely 
embedded in the MCC i.e. in the plastic material. As the 
compaction pressure applied, tablet can be compacted to higher 
density because of plastic flow of material. Thus tablet porosity is 
reduced along with increased activity loss as rigid lattice of the 
enzyme powder is destroyed. In addition, the shearing forces are 
higher with a dominance of MCC because particle movement is 
bigger as compared to lattice dominated by the brittle substance. 
This mixture range should therefore be avoided to get robust 
formulations because at that mixture range a sudden change in the 
behaviour of the system occurs. Thus, the plastic powder (MCC) 
does not work as the protecting substance during compression. 
 
 
Figure 6. Relationship between percentage enzyme activity 
remaining and the amount of enzyme (%) at different critical 
density of binary mixtures of enzyme with MCC. 
Conclusions 
The activity of investigated model enzyme đ- Amylase was 
negatively influenced by the application of compaction pressure, 
whereas the extent of activity loss was dependent on the 
compression character of compacted substances. Compression 
properties of α- Amylase studied with excipients showed that 
enzyme powder compressed alone had greater loss in enzyme 
activity compared to combinations with excipients like carrageenan, 
tragacanth and agar. On the contrary MCC and DCP did not show 
protection to enzyme activity similar to carrageenan, agar and 
tragacanth. However, MCC provided higher protection during 
stability study. The compaction behaviour of enzyme with varying 
concentration of MCC indicated that increase in MCC content in 
binary mixture increased the apparent density of compact with 
reduced porosity. The higher concentration of MCC, probably as 
the dominant particles do not protect the enzyme with their plastic 
deformation. They do possibly crush the particles of the enzyme 
powder and cause high shearing forces on the enzyme. The 
percolation threshold, i.e. the change in the system dominance was 
found to be at a mixture ratio of 37.23 (w / w) of đ- Amylase enzyme 
powder. Below the percolation threshold i.e. < 40 % (w / w) for α- 
Amylase powder, there was steep decrease in enzyme activity. 
This mixture range should therefore be avoided to get robust 
formulations because at that mixture range a sudden change in the 
behaviour of the system occurs and the expected protecting effect 
of the plastic excipient on the brittle α- Amylase enzyme powder 
was therefore not found.   
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